Description

(4E,10Z,16Bs)-7,14,16-Tribromo-5-Chloro-6,9-Dihydro-9,9-Dimethylazeto[1',2':1,2]Imidazo[4',5':7,8]Azecino[3,2-B]Indole-2(1H)-One is a complex, high-purity heterocyclic organic compound featuring a unique fused ring system with halogen substituents. This structurally sophisticated molecule serves as a critical advanced intermediate in the synthesis of novel pharmacologically active compounds. It is primarily required by research institutions and pharmaceutical R&D departments engaged in developing new therapeutic agents, particularly in oncology and central nervous system (CNS) drug discovery.

Application

• Pharmaceutical Intermediate: Key building block for the synthesis of novel, high-value active pharmaceutical ingredients (APIs) with potential anticancer or neuroactive properties.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to explore new chemical entities and optimize drug candidate profiles.
• Organic Synthesis Reference Standard: Serves as a high-purity standard for analytical method development and validation in complex molecule synthesis.
• Biochemical Probe Development: Potential utility in creating specialized probes for studying biological pathways and target interactions.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and scale-up of complex molecules for clinical trials.

Basic Information

Product Name	(4E,10Z,16Bs)-7,14,16-Tribromo-5-Chloro-6,9-Dihydro-9,9-Dimethylazeto[1',2':1,2]Imidazo[4',5':7,8]Azecino[3,2-B]Indole-2(1H)-One
CAS No.	110271-21-1
Molecular Formula	C20H15Br3ClN4O
Molecular Weight	581.52 g/mol
Synonyms	7,14,16-Tribromo-5-chloro-6,9-dihydro-9,9-dimethylazeto[1',2':1,2]imidazo[4',5':7,8]azecino[3,2-b]indol-2(1H)-one; Tribromo-chloro-dimethylazetoimidazoazecinoindolone; CAS 110271-21-1; Azeto[1',2':1,2]imidazo[4',5':7,8]azecino[3,2-b]indole derivative; Halogenated fused heterocycle intermediate; Advanced pharmaceutical building block
EINECS	Contact for details

Quality Control

Our high-purity pharmaceutical intermediate is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical characterization using techniques including HPLC, NMR, and mass spectrometry to confirm identity and purity. Certificates of Analysis (COA) detailing all specifications are provided with every shipment to ensure traceability and batch-to-batch consistency for your critical R&D and scale-up processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound may be light-sensitive and should be handled under an inert atmosphere for long-term stability. Keep container tightly sealed in a dry environment to minimize exposure to moisture.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.